Tag Archives: Takeda

New York Pharma Forum: Together We Stand

Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Posted in Biotech, Events, People, R&D, Strategy, Technology, leadership | Also tagged , , , , , , , , , , | Leave a comment

Takeda Launches New Plan, Cuts US Jobs

Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.” The punch line, however, isn’t too funny. According to a two-year mid-range plan announced yesterday, Takeda will cut about 1,400 positions in the US to fend off [...]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

Avandia Trial in Trouble

GSK’s Avandia just won’t stay out of the news. Now comes a report from The Wall Street Journal that the FDA is considering dealing the beleaguered diabetes drug another blow by stopping one of its safety trials. The TIDE trial, which received approval in 2007, pits Avandia (rosiglitazone) against Takeda’s Actos (pioglitazone), a drug that [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant

Takeda’s US subsidiary launched its proton pump inhibitor dexlansoprazole last February under the name Kapidex. No one thought they’d have to find a new name a year later. But shortly after the launch, the company began getting reports of dispensing errors. Some were due to prescription misreading, others to simple, honest mistakes. The two drugs causing [...]
Posted in Corporate Responsibility, FDA, Marketing, News, Safety, Strategy | Also tagged , , , , , , , , , | 2 Comments

Gearing up: HBA Leadership Conference

Two thousand and eight seems to be a year of unprecedented female leadership. Forget for a second (if you can) the run-off for the Presidential election. If you just consider healthcare, the ladies are really stepping up—and making all the right moves. Consider a few examples: J&J names Sheri McCoy worldwide chairman of pharmaceuticals [...]
Posted in Events, Strategy | Also tagged , , , , , , , | Leave a comment